Figure 1
From: The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
Fibroblast growth factor receptor 1 and fibroblast growth factor receptor substrate 2 alpha expression. Intensity levels were stratified using the Ariol imaging platform (higher number corresponds to higher intensity) in renal cell carcinoma. Non-tumor tissue was excluded from analysis. (A)In situ hybridization for localization of FGFR1 message. (B) FRS2α immunofluorescence.